Essex Investment Management’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-21,969	Closed	-$502K	–	412
2018 Q2	$502K	Buy	+21,969	New	+$502K	0.06%	291